nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.0974	0.162	CbGbCtD
Docetaxel—ABCG2—Leflunomide—systemic scleroderma	0.0729	0.122	CbGbCtD
Docetaxel—ABCC10—Methotrexate—systemic scleroderma	0.0699	0.117	CbGbCtD
Docetaxel—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0498	0.083	CbGbCtD
Docetaxel—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.045	0.0751	CbGbCtD
Docetaxel—SLCO1B3—Methotrexate—systemic scleroderma	0.039	0.0651	CbGbCtD
Docetaxel—SLC22A7—Methotrexate—systemic scleroderma	0.0344	0.0573	CbGbCtD
Docetaxel—ABCB1—Lisinopril—systemic scleroderma	0.0276	0.0459	CbGbCtD
Docetaxel—ABCC1—Methotrexate—systemic scleroderma	0.027	0.045	CbGbCtD
Docetaxel—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.025	0.0416	CbGbCtD
Docetaxel—ABCB1—Captopril—systemic scleroderma	0.0206	0.0344	CbGbCtD
Docetaxel—ABCC2—Methotrexate—systemic scleroderma	0.02	0.0333	CbGbCtD
Docetaxel—ABCG2—Methotrexate—systemic scleroderma	0.0181	0.0301	CbGbCtD
Docetaxel—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0162	0.0271	CbGbCtD
Docetaxel—ABCB1—Prednisone—systemic scleroderma	0.013	0.0216	CbGbCtD
Docetaxel—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00973	0.0162	CbGbCtD
Docetaxel—CYP3A4—Prednisone—systemic scleroderma	0.00778	0.013	CbGbCtD
Docetaxel—ABCB1—Methotrexate—systemic scleroderma	0.00651	0.0109	CbGbCtD
Docetaxel—KIF11—tendon—systemic scleroderma	0.00333	0.0423	CbGeAlD
Docetaxel—KIF11—lung—systemic scleroderma	0.00293	0.0371	CbGeAlD
Docetaxel—NR1I2—digestive system—systemic scleroderma	0.00247	0.0313	CbGeAlD
Docetaxel—TUBB3—connective tissue—systemic scleroderma	0.00224	0.0284	CbGeAlD
Docetaxel—MAP4—connective tissue—systemic scleroderma	0.00224	0.0284	CbGeAlD
Docetaxel—BCL2—connective tissue—systemic scleroderma	0.00203	0.0258	CbGeAlD
Docetaxel—MAP4—skin of body—systemic scleroderma	0.00202	0.0256	CbGeAlD
Docetaxel—MAPT—tendon—systemic scleroderma	0.00195	0.0248	CbGeAlD
Docetaxel—BCL2—smooth muscle tissue—systemic scleroderma	0.00186	0.0236	CbGeAlD
Docetaxel—BCL2—skin of body—systemic scleroderma	0.00183	0.0233	CbGeAlD
Docetaxel—MAP4—digestive system—systemic scleroderma	0.00161	0.0205	CbGeAlD
Docetaxel—TUBB3—digestive system—systemic scleroderma	0.00161	0.0205	CbGeAlD
Docetaxel—MAP4—tendon—systemic scleroderma	0.00154	0.0195	CbGeAlD
Docetaxel—BCL2—digestive system—systemic scleroderma	0.00147	0.0186	CbGeAlD
Docetaxel—TUBB4A—connective tissue—systemic scleroderma	0.00136	0.0173	CbGeAlD
Docetaxel—MAP4—lung—systemic scleroderma	0.00135	0.0171	CbGeAlD
Docetaxel—TUBB3—lung—systemic scleroderma	0.00135	0.0171	CbGeAlD
Docetaxel—TUBB2B—connective tissue—systemic scleroderma	0.00131	0.0167	CbGeAlD
Docetaxel—MAP2—digestive system—systemic scleroderma	0.00127	0.0161	CbGeAlD
Docetaxel—TUBB2A—connective tissue—systemic scleroderma	0.00124	0.0157	CbGeAlD
Docetaxel—TUBB4A—skin of body—systemic scleroderma	0.00123	0.0156	CbGeAlD
Docetaxel—BCL2—lung—systemic scleroderma	0.00123	0.0156	CbGeAlD
Docetaxel—EGFR—lung—systemic scleroderma	0.00121	0.0154	CbGeAlD
Docetaxel—MAP2—tendon—systemic scleroderma	0.00121	0.0154	CbGeAlD
Docetaxel—SLCO1B3—lung—systemic scleroderma	0.00118	0.015	CbGeAlD
Docetaxel—TUBB—smooth muscle tissue—systemic scleroderma	0.00114	0.0144	CbGeAlD
Docetaxel—TUBB2A—smooth muscle tissue—systemic scleroderma	0.00113	0.0144	CbGeAlD
Docetaxel—TUBB2A—skin of body—systemic scleroderma	0.00112	0.0142	CbGeAlD
Docetaxel—TUBB6—smooth muscle tissue—systemic scleroderma	0.00112	0.0142	CbGeAlD
Docetaxel—TUBB6—skin of body—systemic scleroderma	0.0011	0.014	CbGeAlD
Docetaxel—SLC22A7—digestive system—systemic scleroderma	0.0011	0.014	CbGeAlD
Docetaxel—MAP2—lung—systemic scleroderma	0.00106	0.0135	CbGeAlD
Docetaxel—TUBB4B—connective tissue—systemic scleroderma	0.00106	0.0135	CbGeAlD
Docetaxel—TUBB4A—digestive system—systemic scleroderma	0.000983	0.0125	CbGeAlD
Docetaxel—TUBB4B—smooth muscle tissue—systemic scleroderma	0.000971	0.0123	CbGeAlD
Docetaxel—TUBB4B—skin of body—systemic scleroderma	0.000958	0.0122	CbGeAlD
Docetaxel—TUBB2B—digestive system—systemic scleroderma	0.00095	0.0121	CbGeAlD
Docetaxel—TUBB4A—tendon—systemic scleroderma	0.000935	0.0119	CbGeAlD
Docetaxel—TUBB2B—tendon—systemic scleroderma	0.000904	0.0115	CbGeAlD
Docetaxel—TUBB2A—digestive system—systemic scleroderma	0.000894	0.0113	CbGeAlD
Docetaxel—TUBB6—digestive system—systemic scleroderma	0.000882	0.0112	CbGeAlD
Docetaxel—TUBB—tendon—systemic scleroderma	0.000855	0.0109	CbGeAlD
Docetaxel—TUBB2A—tendon—systemic scleroderma	0.000851	0.0108	CbGeAlD
Docetaxel—CYP1B1—connective tissue—systemic scleroderma	0.00084	0.0107	CbGeAlD
Docetaxel—TUBB6—tendon—systemic scleroderma	0.000839	0.0107	CbGeAlD
Docetaxel—TUBB4A—lung—systemic scleroderma	0.000821	0.0104	CbGeAlD
Docetaxel—TUBB2B—lung—systemic scleroderma	0.000793	0.0101	CbGeAlD
Docetaxel—ABCC10—digestive system—systemic scleroderma	0.000772	0.0098	CbGeAlD
Docetaxel—CYP1B1—smooth muscle tissue—systemic scleroderma	0.000769	0.00976	CbGeAlD
Docetaxel—TUBB4B—digestive system—systemic scleroderma	0.000766	0.00973	CbGeAlD
Docetaxel—CYP1B1—skin of body—systemic scleroderma	0.000759	0.00963	CbGeAlD
Docetaxel—TUBB—lung—systemic scleroderma	0.000751	0.00953	CbGeAlD
Docetaxel—TUBB2A—lung—systemic scleroderma	0.000747	0.00948	CbGeAlD
Docetaxel—TUBB6—lung—systemic scleroderma	0.000736	0.00935	CbGeAlD
Docetaxel—ABCC10—tendon—systemic scleroderma	0.000735	0.00933	CbGeAlD
Docetaxel—TUBB4B—tendon—systemic scleroderma	0.000729	0.00926	CbGeAlD
Docetaxel—ABCC10—lung—systemic scleroderma	0.000645	0.00818	CbGeAlD
Docetaxel—TUBB4B—lung—systemic scleroderma	0.00064	0.00813	CbGeAlD
Docetaxel—ABCC2—digestive system—systemic scleroderma	0.00062	0.00787	CbGeAlD
Docetaxel—CYP1B1—digestive system—systemic scleroderma	0.000607	0.00771	CbGeAlD
Docetaxel—ABCB1—blood vessel—systemic scleroderma	0.000602	0.00764	CbGeAlD
Docetaxel—ABCC2—tendon—systemic scleroderma	0.00059	0.00749	CbGeAlD
Docetaxel—CYP1B1—tendon—systemic scleroderma	0.000578	0.00733	CbGeAlD
Docetaxel—ABCC1—tendon—systemic scleroderma	0.00052	0.0066	CbGeAlD
Docetaxel—CYP1B1—lung—systemic scleroderma	0.000507	0.00644	CbGeAlD
Docetaxel—ABCC1—lung—systemic scleroderma	0.000456	0.00579	CbGeAlD
Docetaxel—CYP3A5—digestive system—systemic scleroderma	0.00042	0.00533	CbGeAlD
Docetaxel—ABCG2—lung—systemic scleroderma	0.000377	0.00479	CbGeAlD
Docetaxel—CYP3A5—lung—systemic scleroderma	0.00035	0.00445	CbGeAlD
Docetaxel—CYP3A4—digestive system—systemic scleroderma	0.000315	0.004	CbGeAlD
Docetaxel—GHRHR—GPCR downstream signaling—RHOB—systemic scleroderma	0.000244	0.00545	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—SELP—systemic scleroderma	0.000241	0.00537	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—CENPC—systemic scleroderma	0.00024	0.00534	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—SMAD7—systemic scleroderma	0.000239	0.00532	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—IL1A—systemic scleroderma	0.000237	0.00528	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	0.000234	0.00521	CbGpPWpGaD
Docetaxel—EGFR—GAB1 signalosome—CSK—systemic scleroderma	0.00023	0.00513	CbGpPWpGaD
Docetaxel—MAPT—Alzheimers Disease—IL1B—systemic scleroderma	0.000226	0.00504	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—RHOB—systemic scleroderma	0.000225	0.00502	CbGpPWpGaD
Docetaxel—ABCB1—digestive system—systemic scleroderma	0.000223	0.00283	CbGeAlD
Docetaxel—BCL2—Focal Adhesion—ITGAM—systemic scleroderma	0.000223	0.00496	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000222	0.00495	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—RHOB—systemic scleroderma	0.000222	0.00495	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—EDN1—systemic scleroderma	0.000221	0.00492	CbGpPWpGaD
Docetaxel—BCL2—ATF-2 transcription factor network—MMP2—systemic scleroderma	0.00022	0.00491	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—CENPC—systemic scleroderma	0.000219	0.00488	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CSK—systemic scleroderma	0.000217	0.00484	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—CENPC—systemic scleroderma	0.000214	0.00477	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IRF5—systemic scleroderma	0.000214	0.00476	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—IL1A—systemic scleroderma	0.000212	0.00473	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.00021	0.00468	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—BLK—systemic scleroderma	0.000206	0.00459	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IRF8—systemic scleroderma	0.000204	0.00455	CbGpPWpGaD
Docetaxel—KIF11—Immune System—ITGAM—systemic scleroderma	0.000204	0.00455	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD247—systemic scleroderma	0.000204	0.00455	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CD40LG—systemic scleroderma	0.000199	0.00442	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CENPC—systemic scleroderma	0.000196	0.00436	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—MMP1—systemic scleroderma	0.000195	0.00435	CbGpPWpGaD
Docetaxel—KIF11—Immune System—TNFAIP3—systemic scleroderma	0.000191	0.00426	CbGpPWpGaD
Docetaxel—KIF11—Immune System—BLK—systemic scleroderma	0.000189	0.00421	CbGpPWpGaD
Docetaxel—ABCB1—lung—systemic scleroderma	0.000186	0.00236	CbGeAlD
Docetaxel—TUBB—Cell Cycle, Mitotic—CENPA—systemic scleroderma	0.000184	0.00409	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—IRF5—systemic scleroderma	0.000176	0.00392	CbGpPWpGaD
Docetaxel—BCL2—Interleukin-11 Signaling Pathway—TGFB1—systemic scleroderma	0.000173	0.00384	CbGpPWpGaD
Docetaxel—ABCG2—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.000171	0.00381	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Actin Cytoskeleton—CSK—systemic scleroderma	0.00017	0.00379	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—SMAD7—systemic scleroderma	0.00017	0.00378	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—CENPA—systemic scleroderma	0.000164	0.00366	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—CSK—systemic scleroderma	0.000159	0.00355	CbGpPWpGaD
Docetaxel—BCL2—IL-3 Signaling Pathway—TGFB1—systemic scleroderma	0.000158	0.00353	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CTLA4—systemic scleroderma	0.000155	0.00345	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—RHOB—systemic scleroderma	0.000154	0.00343	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—CENPA—systemic scleroderma	0.000152	0.00339	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—CCL2—systemic scleroderma	0.000151	0.00336	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—CSK—systemic scleroderma	0.000147	0.00327	CbGpPWpGaD
Docetaxel—NR1I2—Generic Transcription Pathway—CTGF—systemic scleroderma	0.000146	0.00326	CbGpPWpGaD
Docetaxel—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000528	CcSEcCtD
Docetaxel—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000527	CcSEcCtD
Docetaxel—EGFR—Signaling by EGFR in Cancer—CSK—systemic scleroderma	0.000146	0.00324	CbGpPWpGaD
Docetaxel—Feeling abnormal—Leflunomide—systemic scleroderma	0.000145	0.000526	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000145	0.000526	CcSEcCtD
Docetaxel—Fatigue—Mycophenolic acid—systemic scleroderma	0.000145	0.000525	CcSEcCtD
Docetaxel—EGFR—Focal Adhesion—COL1A2—systemic scleroderma	0.000145	0.00323	CbGpPWpGaD
Docetaxel—Nausea—Mometasone—systemic scleroderma	0.000145	0.000524	CcSEcCtD
Docetaxel—BCL2—Corticotropin-releasing hormone—NOS3—systemic scleroderma	0.000145	0.00322	CbGpPWpGaD
Docetaxel—Anorexia—Lisinopril—systemic scleroderma	0.000145	0.000523	CcSEcCtD
Docetaxel—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000144	0.000522	CcSEcCtD
Docetaxel—Weight increased—Prednisone—systemic scleroderma	0.000144	0.000522	CcSEcCtD
Docetaxel—Ataxia—Methotrexate—systemic scleroderma	0.000144	0.000521	CcSEcCtD
Docetaxel—Constipation—Mycophenolic acid—systemic scleroderma	0.000144	0.000521	CcSEcCtD
Docetaxel—Pain—Mycophenolic acid—systemic scleroderma	0.000144	0.000521	CcSEcCtD
Docetaxel—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000521	CcSEcCtD
Docetaxel—Weight decreased—Prednisone—systemic scleroderma	0.000143	0.000519	CcSEcCtD
Docetaxel—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000518	CcSEcCtD
Docetaxel—Cough—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000514	CcSEcCtD
Docetaxel—Hypotension—Lisinopril—systemic scleroderma	0.000142	0.000513	CcSEcCtD
Docetaxel—Dizziness—Captopril—systemic scleroderma	0.000142	0.000512	CcSEcCtD
Docetaxel—KIF11—Hemostasis—NOS3—systemic scleroderma	0.000142	0.00315	CbGpPWpGaD
Docetaxel—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000141	0.000512	CcSEcCtD
Docetaxel—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00051	CcSEcCtD
Docetaxel—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000509	CcSEcCtD
Docetaxel—Abdominal pain—Leflunomide—systemic scleroderma	0.00014	0.000505	CcSEcCtD
Docetaxel—Body temperature increased—Leflunomide—systemic scleroderma	0.00014	0.000505	CcSEcCtD
Docetaxel—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000139	0.000504	CcSEcCtD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—CENPA—systemic scleroderma	0.000139	0.0031	CbGpPWpGaD
Docetaxel—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000139	0.000502	CcSEcCtD
Docetaxel—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000502	CcSEcCtD
Docetaxel—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000502	CcSEcCtD
Docetaxel—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000502	CcSEcCtD
Docetaxel—EGFR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—systemic scleroderma	0.000139	0.00309	CbGpPWpGaD
Docetaxel—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000138	0.000501	CcSEcCtD
Docetaxel—Myocardial infarction—Prednisone—systemic scleroderma	0.000138	0.000501	CcSEcCtD
Docetaxel—Breast disorder—Methotrexate—systemic scleroderma	0.000138	0.000501	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000138	0.0005	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000138	0.000499	CcSEcCtD
Docetaxel—Hypersensitivity—Azathioprine—systemic scleroderma	0.000138	0.000498	CcSEcCtD
Docetaxel—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000138	0.000498	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000498	CcSEcCtD
Docetaxel—Insomnia—Lisinopril—systemic scleroderma	0.000137	0.000496	CcSEcCtD
Docetaxel—Paraesthesia—Lisinopril—systemic scleroderma	0.000136	0.000493	CcSEcCtD
Docetaxel—Vomiting—Captopril—systemic scleroderma	0.000136	0.000493	CcSEcCtD
Docetaxel—TUBB4A—Cell Cycle—CENPA—systemic scleroderma	0.000136	0.00303	CbGpPWpGaD
Docetaxel—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000491	CcSEcCtD
Docetaxel—Dyspnoea—Lisinopril—systemic scleroderma	0.000135	0.000489	CcSEcCtD
Docetaxel—Rash—Captopril—systemic scleroderma	0.000135	0.000489	CcSEcCtD
Docetaxel—Dermatitis—Captopril—systemic scleroderma	0.000135	0.000488	CcSEcCtD
Docetaxel—Somnolence—Lisinopril—systemic scleroderma	0.000135	0.000488	CcSEcCtD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	0.000134	0.00299	CbGpPWpGaD
Docetaxel—Headache—Captopril—systemic scleroderma	0.000134	0.000485	CcSEcCtD
Docetaxel—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000485	CcSEcCtD
Docetaxel—Dyspepsia—Lisinopril—systemic scleroderma	0.000134	0.000483	CcSEcCtD
Docetaxel—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000133	0.000482	CcSEcCtD
Docetaxel—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000133	0.000482	CcSEcCtD
Docetaxel—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000481	CcSEcCtD
Docetaxel—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000481	CcSEcCtD
Docetaxel—Infection—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000478	CcSEcCtD
Docetaxel—Decreased appetite—Lisinopril—systemic scleroderma	0.000132	0.000477	CcSEcCtD
Docetaxel—EGFR—Focal Adhesion—ITGAM—systemic scleroderma	0.000132	0.00293	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—RHOB—systemic scleroderma	0.000131	0.00292	CbGpPWpGaD
Docetaxel—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000131	0.000474	CcSEcCtD
Docetaxel—Fatigue—Lisinopril—systemic scleroderma	0.000131	0.000473	CcSEcCtD
Docetaxel—Shock—Mycophenolate mofetil—systemic scleroderma	0.000131	0.000473	CcSEcCtD
Docetaxel—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000472	CcSEcCtD
Docetaxel—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000471	CcSEcCtD
Docetaxel—Hypersensitivity—Leflunomide—systemic scleroderma	0.00013	0.000471	CcSEcCtD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.00013	0.0029	CbGpPWpGaD
Docetaxel—Constipation—Lisinopril—systemic scleroderma	0.00013	0.000469	CcSEcCtD
Docetaxel—Pain—Lisinopril—systemic scleroderma	0.00013	0.000469	CcSEcCtD
Docetaxel—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000469	CcSEcCtD
Docetaxel—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000129	0.000467	CcSEcCtD
Docetaxel—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—systemic scleroderma	0.000128	0.00286	CbGpPWpGaD
Docetaxel—Diarrhoea—Azathioprine—systemic scleroderma	0.000128	0.000463	CcSEcCtD
Docetaxel—KIF11—Immune System—HLA-DQB1—systemic scleroderma	0.000127	0.00284	CbGpPWpGaD
Docetaxel—Haemoglobin—Prednisone—systemic scleroderma	0.000127	0.000461	CcSEcCtD
Docetaxel—NR1I2—Gene Expression—SMAD7—systemic scleroderma	0.000127	0.00284	CbGpPWpGaD
Docetaxel—Nausea—Captopril—systemic scleroderma	0.000127	0.00046	CcSEcCtD
Docetaxel—EGFR—Thromboxane A2 receptor signaling—NOS3—systemic scleroderma	0.000127	0.00283	CbGpPWpGaD
Docetaxel—Haemorrhage—Prednisone—systemic scleroderma	0.000127	0.000459	CcSEcCtD
Docetaxel—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000458	CcSEcCtD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.000127	0.00282	CbGpPWpGaD
Docetaxel—Asthenia—Leflunomide—systemic scleroderma	0.000127	0.000458	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—IL13—systemic scleroderma	0.000126	0.00282	CbGpPWpGaD
Docetaxel—Pancytopenia—Methotrexate—systemic scleroderma	0.000126	0.000455	CcSEcCtD
Docetaxel—Feeling abnormal—Lisinopril—systemic scleroderma	0.000125	0.000452	CcSEcCtD
Docetaxel—Pruritus—Leflunomide—systemic scleroderma	0.000125	0.000452	CcSEcCtD
Docetaxel—GHRHR—GPCR downstream signaling—EDN1—systemic scleroderma	0.000125	0.00278	CbGpPWpGaD
Docetaxel—Connective tissue disorder—Prednisone—systemic scleroderma	0.000125	0.000451	CcSEcCtD
Docetaxel—TUBB4B—Cell Cycle—CENPA—systemic scleroderma	0.000124	0.00277	CbGpPWpGaD
Docetaxel—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000449	CcSEcCtD
Docetaxel—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000124	0.000449	CcSEcCtD
Docetaxel—Neutropenia—Methotrexate—systemic scleroderma	0.000124	0.000448	CcSEcCtD
Docetaxel—GHRHR—Signaling Pathways—HSPG2—systemic scleroderma	0.000124	0.00275	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—NOS3—systemic scleroderma	0.000124	0.00275	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—IL1B—systemic scleroderma	0.000124	0.00275	CbGpPWpGaD
Docetaxel—Dizziness—Azathioprine—systemic scleroderma	0.000124	0.000447	CcSEcCtD
Docetaxel—EGFR—LPA receptor mediated events—MMP2—systemic scleroderma	0.000122	0.00272	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—BLK—systemic scleroderma	0.000122	0.00272	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL1A—systemic scleroderma	0.000121	0.0027	CbGpPWpGaD
Docetaxel—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000438	CcSEcCtD
Docetaxel—Asthenia—Mycophenolic acid—systemic scleroderma	0.000121	0.000437	CcSEcCtD
Docetaxel—Diarrhoea—Leflunomide—systemic scleroderma	0.000121	0.000437	CcSEcCtD
Docetaxel—KIF11—Immune System—CD40LG—systemic scleroderma	0.00012	0.00268	CbGpPWpGaD
Docetaxel—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00012	0.000435	CcSEcCtD
Docetaxel—Abdominal pain—Lisinopril—systemic scleroderma	0.00012	0.000434	CcSEcCtD
Docetaxel—Body temperature increased—Lisinopril—systemic scleroderma	0.00012	0.000434	CcSEcCtD
Docetaxel—GHRHR—Signaling Pathways—CSK—systemic scleroderma	0.000119	0.00266	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—BLK—systemic scleroderma	0.000119	0.00266	CbGpPWpGaD
Docetaxel—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000432	CcSEcCtD
Docetaxel—Pruritus—Mycophenolic acid—systemic scleroderma	0.000119	0.000431	CcSEcCtD
Docetaxel—EGFR—AGE/RAGE pathway—MMP2—systemic scleroderma	0.000119	0.00265	CbGpPWpGaD
Docetaxel—Vomiting—Azathioprine—systemic scleroderma	0.000119	0.00043	CcSEcCtD
Docetaxel—Pneumonia—Methotrexate—systemic scleroderma	0.000119	0.00043	CcSEcCtD
Docetaxel—Eye disorder—Prednisone—systemic scleroderma	0.000118	0.000429	CcSEcCtD
Docetaxel—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000429	CcSEcCtD
Docetaxel—NR1I2—Gene Expression—TNFSF13—systemic scleroderma	0.000118	0.00264	CbGpPWpGaD
Docetaxel—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000427	CcSEcCtD
Docetaxel—Infestation NOS—Methotrexate—systemic scleroderma	0.000118	0.000427	CcSEcCtD
Docetaxel—Infestation—Methotrexate—systemic scleroderma	0.000118	0.000427	CcSEcCtD
Docetaxel—Rash—Azathioprine—systemic scleroderma	0.000118	0.000426	CcSEcCtD
Docetaxel—Dermatitis—Azathioprine—systemic scleroderma	0.000118	0.000426	CcSEcCtD
Docetaxel—Flushing—Prednisone—systemic scleroderma	0.000118	0.000426	CcSEcCtD
Docetaxel—Headache—Azathioprine—systemic scleroderma	0.000117	0.000424	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000117	0.000423	CcSEcCtD
Docetaxel—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000423	CcSEcCtD
Docetaxel—Dizziness—Leflunomide—systemic scleroderma	0.000117	0.000422	CcSEcCtD
Docetaxel—Renal failure—Methotrexate—systemic scleroderma	0.000116	0.00042	CcSEcCtD
Docetaxel—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000116	0.000418	CcSEcCtD
Docetaxel—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000115	0.000417	CcSEcCtD
Docetaxel—Stomatitis—Methotrexate—systemic scleroderma	0.000115	0.000416	CcSEcCtD
Docetaxel—Angiopathy—Prednisone—systemic scleroderma	0.000115	0.000416	CcSEcCtD
Docetaxel—Conjunctivitis—Methotrexate—systemic scleroderma	0.000115	0.000415	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000115	0.000415	CcSEcCtD
Docetaxel—Immune system disorder—Prednisone—systemic scleroderma	0.000115	0.000414	CcSEcCtD
Docetaxel—EGFR—Spinal Cord Injury—IL1A—systemic scleroderma	0.000114	0.00255	CbGpPWpGaD
Docetaxel—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000411	CcSEcCtD
Docetaxel—Pain—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000411	CcSEcCtD
Docetaxel—GHRHR—Signaling by GPCR—EDN1—systemic scleroderma	0.000113	0.00252	CbGpPWpGaD
Docetaxel—Arrhythmia—Prednisone—systemic scleroderma	0.000113	0.00041	CcSEcCtD
Docetaxel—Vomiting—Leflunomide—systemic scleroderma	0.000112	0.000406	CcSEcCtD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000112	0.0025	CbGpPWpGaD
Docetaxel—Alopecia—Prednisone—systemic scleroderma	0.000112	0.000405	CcSEcCtD
Docetaxel—Hypersensitivity—Lisinopril—systemic scleroderma	0.000112	0.000404	CcSEcCtD
Docetaxel—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000112	0.000404	CcSEcCtD
Docetaxel—EGFR—AGE/RAGE pathway—NOS3—systemic scleroderma	0.000112	0.00248	CbGpPWpGaD
Docetaxel—Dizziness—Mycophenolic acid—systemic scleroderma	0.000111	0.000403	CcSEcCtD
Docetaxel—Epistaxis—Methotrexate—systemic scleroderma	0.000111	0.000403	CcSEcCtD
Docetaxel—Rash—Leflunomide—systemic scleroderma	0.000111	0.000403	CcSEcCtD
Docetaxel—Dermatitis—Leflunomide—systemic scleroderma	0.000111	0.000402	CcSEcCtD
Docetaxel—Mental disorder—Prednisone—systemic scleroderma	0.000111	0.000402	CcSEcCtD
Docetaxel—Nausea—Azathioprine—systemic scleroderma	0.000111	0.000402	CcSEcCtD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—IL1B—systemic scleroderma	0.000111	0.00247	CbGpPWpGaD
Docetaxel—Headache—Leflunomide—systemic scleroderma	0.000111	0.0004	CcSEcCtD
Docetaxel—Erythema—Prednisone—systemic scleroderma	0.00011	0.000399	CcSEcCtD
Docetaxel—Malnutrition—Prednisone—systemic scleroderma	0.00011	0.000399	CcSEcCtD
Docetaxel—BCL2—Direct p53 effectors—MMP2—systemic scleroderma	0.00011	0.00246	CbGpPWpGaD
Docetaxel—Agranulocytosis—Methotrexate—systemic scleroderma	0.00011	0.000399	CcSEcCtD
Docetaxel—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000396	CcSEcCtD
Docetaxel—Asthenia—Lisinopril—systemic scleroderma	0.000109	0.000394	CcSEcCtD
Docetaxel—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000393	CcSEcCtD
Docetaxel—Pruritus—Lisinopril—systemic scleroderma	0.000107	0.000388	CcSEcCtD
Docetaxel—Vomiting—Mycophenolic acid—systemic scleroderma	0.000107	0.000387	CcSEcCtD
Docetaxel—Haemoglobin—Methotrexate—systemic scleroderma	0.000106	0.000385	CcSEcCtD
Docetaxel—Rash—Mycophenolic acid—systemic scleroderma	0.000106	0.000384	CcSEcCtD
Docetaxel—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000106	0.000384	CcSEcCtD
Docetaxel—Haemorrhage—Methotrexate—systemic scleroderma	0.000106	0.000383	CcSEcCtD
Docetaxel—Hepatitis—Methotrexate—systemic scleroderma	0.000106	0.000383	CcSEcCtD
Docetaxel—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—systemic scleroderma	0.000106	0.00236	CbGpPWpGaD
Docetaxel—Headache—Mycophenolic acid—systemic scleroderma	0.000105	0.000382	CcSEcCtD
Docetaxel—Pharyngitis—Methotrexate—systemic scleroderma	0.000105	0.000381	CcSEcCtD
Docetaxel—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000105	0.00038	CcSEcCtD
Docetaxel—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000105	0.00038	CcSEcCtD
Docetaxel—Nausea—Leflunomide—systemic scleroderma	0.000105	0.000379	CcSEcCtD
Docetaxel—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000105	0.000379	CcSEcCtD
Docetaxel—Urethral disorder—Methotrexate—systemic scleroderma	0.000104	0.000376	CcSEcCtD
Docetaxel—Diarrhoea—Lisinopril—systemic scleroderma	0.000104	0.000376	CcSEcCtD
Docetaxel—Visual impairment—Methotrexate—systemic scleroderma	0.000102	0.00037	CcSEcCtD
Docetaxel—Anaemia—Prednisone—systemic scleroderma	0.000102	0.000369	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—CTLA4—systemic scleroderma	0.000102	0.00227	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000101	0.00225	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—RHOB—systemic scleroderma	0.0001	0.00224	CbGpPWpGaD
Docetaxel—Dizziness—Lisinopril—systemic scleroderma	0.0001	0.000363	CcSEcCtD
Docetaxel—Erythema multiforme—Methotrexate—systemic scleroderma	0.0001	0.000363	CcSEcCtD
Docetaxel—Nausea—Mycophenolic acid—systemic scleroderma	0.0001	0.000362	CcSEcCtD
Docetaxel—Eye disorder—Methotrexate—systemic scleroderma	9.9e-05	0.000358	CcSEcCtD
Docetaxel—Syncope—Prednisone—systemic scleroderma	9.9e-05	0.000358	CcSEcCtD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	9.84e-05	0.00219	CbGpPWpGaD
Docetaxel—Cardiac disorder—Methotrexate—systemic scleroderma	9.83e-05	0.000356	CcSEcCtD
Docetaxel—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	9.79e-05	0.000354	CcSEcCtD
Docetaxel—Loss of consciousness—Prednisone—systemic scleroderma	9.7e-05	0.000351	CcSEcCtD
Docetaxel—Vomiting—Lisinopril—systemic scleroderma	9.64e-05	0.000349	CcSEcCtD
Docetaxel—Angiopathy—Methotrexate—systemic scleroderma	9.61e-05	0.000348	CcSEcCtD
Docetaxel—MAPT—MAPK Signaling Pathway—TGFB1—systemic scleroderma	9.61e-05	0.00214	CbGpPWpGaD
Docetaxel—Immune system disorder—Methotrexate—systemic scleroderma	9.57e-05	0.000346	CcSEcCtD
Docetaxel—Rash—Lisinopril—systemic scleroderma	9.56e-05	0.000346	CcSEcCtD
Docetaxel—Convulsion—Prednisone—systemic scleroderma	9.56e-05	0.000346	CcSEcCtD
Docetaxel—BCL2—Corticotropin-releasing hormone—TGFB1—systemic scleroderma	9.56e-05	0.00213	CbGpPWpGaD
Docetaxel—Dermatitis—Lisinopril—systemic scleroderma	9.55e-05	0.000346	CcSEcCtD
Docetaxel—Mediastinal disorder—Methotrexate—systemic scleroderma	9.55e-05	0.000346	CcSEcCtD
Docetaxel—Asthenia—Mycophenolate mofetil—systemic scleroderma	9.53e-05	0.000345	CcSEcCtD
Docetaxel—Hypertension—Prednisone—systemic scleroderma	9.53e-05	0.000345	CcSEcCtD
Docetaxel—Chills—Methotrexate—systemic scleroderma	9.51e-05	0.000344	CcSEcCtD
Docetaxel—Headache—Lisinopril—systemic scleroderma	9.5e-05	0.000344	CcSEcCtD
Docetaxel—Pruritus—Mycophenolate mofetil—systemic scleroderma	9.4e-05	0.00034	CcSEcCtD
Docetaxel—Arthralgia—Prednisone—systemic scleroderma	9.4e-05	0.00034	CcSEcCtD
Docetaxel—Myalgia—Prednisone—systemic scleroderma	9.4e-05	0.00034	CcSEcCtD
Docetaxel—Alopecia—Methotrexate—systemic scleroderma	9.36e-05	0.000339	CcSEcCtD
Docetaxel—KIF11—Hemostasis—TGFB1—systemic scleroderma	9.36e-05	0.00208	CbGpPWpGaD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	9.33e-05	0.000338	CcSEcCtD
Docetaxel—Mental disorder—Methotrexate—systemic scleroderma	9.28e-05	0.000336	CcSEcCtD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	9.24e-05	0.00206	CbGpPWpGaD
Docetaxel—Erythema—Methotrexate—systemic scleroderma	9.22e-05	0.000334	CcSEcCtD
Docetaxel—Malnutrition—Methotrexate—systemic scleroderma	9.22e-05	0.000334	CcSEcCtD
Docetaxel—EGFR—LPA receptor mediated events—MMP9—systemic scleroderma	9.17e-05	0.00204	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—ITGAM—systemic scleroderma	9.16e-05	0.00204	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CD247—systemic scleroderma	9.16e-05	0.00204	CbGpPWpGaD
Docetaxel—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	9.09e-05	0.000329	CcSEcCtD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	9.05e-05	0.00202	CbGpPWpGaD
Docetaxel—Dysgeusia—Methotrexate—systemic scleroderma	9.03e-05	0.000327	CcSEcCtD
Docetaxel—Nausea—Lisinopril—systemic scleroderma	9.01e-05	0.000326	CcSEcCtD
Docetaxel—Oedema—Prednisone—systemic scleroderma	9.01e-05	0.000326	CcSEcCtD
Docetaxel—Anaphylactic shock—Prednisone—systemic scleroderma	9.01e-05	0.000326	CcSEcCtD
Docetaxel—Infection—Prednisone—systemic scleroderma	8.95e-05	0.000324	CcSEcCtD
Docetaxel—EGFR—AGE/RAGE pathway—MMP9—systemic scleroderma	8.95e-05	0.00199	CbGpPWpGaD
Docetaxel—Back pain—Methotrexate—systemic scleroderma	8.92e-05	0.000323	CcSEcCtD
Docetaxel—Shock—Prednisone—systemic scleroderma	8.86e-05	0.000321	CcSEcCtD
Docetaxel—Nervous system disorder—Prednisone—systemic scleroderma	8.83e-05	0.00032	CcSEcCtD
Docetaxel—Tachycardia—Prednisone—systemic scleroderma	8.79e-05	0.000318	CcSEcCtD
Docetaxel—Dizziness—Mycophenolate mofetil—systemic scleroderma	8.79e-05	0.000318	CcSEcCtD
Docetaxel—Skin disorder—Prednisone—systemic scleroderma	8.75e-05	0.000317	CcSEcCtD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	8.67e-05	0.00193	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—IL1A—systemic scleroderma	8.62e-05	0.00192	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—TGFB1—systemic scleroderma	8.6e-05	0.00192	CbGpPWpGaD
Docetaxel—Anorexia—Prednisone—systemic scleroderma	8.59e-05	0.000311	CcSEcCtD
Docetaxel—BCL2—Innate Immune System—TNFAIP3—systemic scleroderma	8.58e-05	0.00191	CbGpPWpGaD
Docetaxel—Anaemia—Methotrexate—systemic scleroderma	8.53e-05	0.000308	CcSEcCtD
Docetaxel—Vomiting—Mycophenolate mofetil—systemic scleroderma	8.45e-05	0.000306	CcSEcCtD
Docetaxel—Rash—Mycophenolate mofetil—systemic scleroderma	8.38e-05	0.000303	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	8.37e-05	0.00187	CbGpPWpGaD
Docetaxel—Dermatitis—Mycophenolate mofetil—systemic scleroderma	8.37e-05	0.000303	CcSEcCtD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—TGFB1—systemic scleroderma	8.35e-05	0.00186	CbGpPWpGaD
Docetaxel—Headache—Mycophenolate mofetil—systemic scleroderma	8.33e-05	0.000301	CcSEcCtD
Docetaxel—Leukopenia—Methotrexate—systemic scleroderma	8.26e-05	0.000299	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Prednisone—systemic scleroderma	8.21e-05	0.000297	CcSEcCtD
Docetaxel—TUBB2B—Metabolism of proteins—ACE—systemic scleroderma	8.17e-05	0.00182	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—ACE—systemic scleroderma	8.17e-05	0.00182	CbGpPWpGaD
Docetaxel—Insomnia—Prednisone—systemic scleroderma	8.15e-05	0.000295	CcSEcCtD
Docetaxel—Paraesthesia—Prednisone—systemic scleroderma	8.09e-05	0.000293	CcSEcCtD
Docetaxel—Cough—Methotrexate—systemic scleroderma	8.05e-05	0.000291	CcSEcCtD
Docetaxel—Convulsion—Methotrexate—systemic scleroderma	7.99e-05	0.000289	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	7.95e-05	0.00177	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	7.93e-05	0.00177	CbGpPWpGaD
Docetaxel—Dyspepsia—Prednisone—systemic scleroderma	7.93e-05	0.000287	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	7.91e-05	0.00176	CbGpPWpGaD
Docetaxel—Nausea—Mycophenolate mofetil—systemic scleroderma	7.89e-05	0.000286	CcSEcCtD
Docetaxel—TUBB3—Metabolism of proteins—ACE—systemic scleroderma	7.89e-05	0.00176	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—CCL2—systemic scleroderma	7.86e-05	0.00175	CbGpPWpGaD
Docetaxel—Chest pain—Methotrexate—systemic scleroderma	7.85e-05	0.000284	CcSEcCtD
Docetaxel—Myalgia—Methotrexate—systemic scleroderma	7.85e-05	0.000284	CcSEcCtD
Docetaxel—Arthralgia—Methotrexate—systemic scleroderma	7.85e-05	0.000284	CcSEcCtD
Docetaxel—Decreased appetite—Prednisone—systemic scleroderma	7.83e-05	0.000283	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	7.8e-05	0.000282	CcSEcCtD
Docetaxel—Fatigue—Prednisone—systemic scleroderma	7.77e-05	0.000281	CcSEcCtD
Docetaxel—GHRHR—Signaling by GPCR—CCL2—systemic scleroderma	7.75e-05	0.00173	CbGpPWpGaD
Docetaxel—Constipation—Prednisone—systemic scleroderma	7.7e-05	0.000279	CcSEcCtD
Docetaxel—TUBB2A—Metabolism of proteins—ACE—systemic scleroderma	7.64e-05	0.0017	CbGpPWpGaD
Docetaxel—Confusional state—Methotrexate—systemic scleroderma	7.59e-05	0.000275	CcSEcCtD
Docetaxel—Anaphylactic shock—Methotrexate—systemic scleroderma	7.53e-05	0.000272	CcSEcCtD
Docetaxel—Infection—Methotrexate—systemic scleroderma	7.48e-05	0.000271	CcSEcCtD
Docetaxel—TUBB1—Metabolism of proteins—ACE—systemic scleroderma	7.47e-05	0.00166	CbGpPWpGaD
Docetaxel—Feeling abnormal—Prednisone—systemic scleroderma	7.42e-05	0.000269	CcSEcCtD
Docetaxel—Nervous system disorder—Methotrexate—systemic scleroderma	7.38e-05	0.000267	CcSEcCtD
Docetaxel—Thrombocytopenia—Methotrexate—systemic scleroderma	7.37e-05	0.000267	CcSEcCtD
Docetaxel—Gastrointestinal pain—Prednisone—systemic scleroderma	7.37e-05	0.000267	CcSEcCtD
Docetaxel—Skin disorder—Methotrexate—systemic scleroderma	7.31e-05	0.000265	CcSEcCtD
Docetaxel—EGFR—Regulation of Telomerase—TGFB1—systemic scleroderma	7.2e-05	0.0016	CbGpPWpGaD
Docetaxel—Anorexia—Methotrexate—systemic scleroderma	7.18e-05	0.00026	CcSEcCtD
Docetaxel—EGFR—Developmental Biology—RHOB—systemic scleroderma	7.16e-05	0.0016	CbGpPWpGaD
Docetaxel—Abdominal pain—Prednisone—systemic scleroderma	7.12e-05	0.000258	CcSEcCtD
Docetaxel—Body temperature increased—Prednisone—systemic scleroderma	7.12e-05	0.000258	CcSEcCtD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—systemic scleroderma	7.12e-05	0.00158	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—CTGF—systemic scleroderma	7.04e-05	0.00157	CbGpPWpGaD
Docetaxel—Hypotension—Methotrexate—systemic scleroderma	7.03e-05	0.000255	CcSEcCtD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	6.86e-05	0.00153	CbGpPWpGaD
Docetaxel—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	6.86e-05	0.000248	CcSEcCtD
Docetaxel—Insomnia—Methotrexate—systemic scleroderma	6.81e-05	0.000246	CcSEcCtD
Docetaxel—Paraesthesia—Methotrexate—systemic scleroderma	6.76e-05	0.000245	CcSEcCtD
Docetaxel—Dyspnoea—Methotrexate—systemic scleroderma	6.71e-05	0.000243	CcSEcCtD
Docetaxel—TUBB4A—Metabolism of proteins—ACE—systemic scleroderma	6.71e-05	0.00149	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EDN1—systemic scleroderma	6.7e-05	0.00149	CbGpPWpGaD
Docetaxel—Somnolence—Methotrexate—systemic scleroderma	6.69e-05	0.000242	CcSEcCtD
Docetaxel—Hypersensitivity—Prednisone—systemic scleroderma	6.64e-05	0.00024	CcSEcCtD
Docetaxel—Dyspepsia—Methotrexate—systemic scleroderma	6.63e-05	0.00024	CcSEcCtD
Docetaxel—Decreased appetite—Methotrexate—systemic scleroderma	6.54e-05	0.000237	CcSEcCtD
Docetaxel—EGFR—Direct p53 effectors—MMP2—systemic scleroderma	6.52e-05	0.00145	CbGpPWpGaD
Docetaxel—Gastrointestinal disorder—Methotrexate—systemic scleroderma	6.5e-05	0.000235	CcSEcCtD
Docetaxel—Fatigue—Methotrexate—systemic scleroderma	6.49e-05	0.000235	CcSEcCtD
Docetaxel—Asthenia—Prednisone—systemic scleroderma	6.46e-05	0.000234	CcSEcCtD
Docetaxel—Pain—Methotrexate—systemic scleroderma	6.44e-05	0.000233	CcSEcCtD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	6.4e-05	0.00143	CbGpPWpGaD
Docetaxel—Pruritus—Prednisone—systemic scleroderma	6.37e-05	0.000231	CcSEcCtD
Docetaxel—KIF11—Immune System—IL1B—systemic scleroderma	6.32e-05	0.00141	CbGpPWpGaD
Docetaxel—Feeling abnormal—Methotrexate—systemic scleroderma	6.2e-05	0.000224	CcSEcCtD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	6.19e-05	0.00138	CbGpPWpGaD
Docetaxel—Diarrhoea—Prednisone—systemic scleroderma	6.16e-05	0.000223	CcSEcCtD
Docetaxel—Gastrointestinal pain—Methotrexate—systemic scleroderma	6.16e-05	0.000223	CcSEcCtD
Docetaxel—TUBB4B—Metabolism of proteins—ACE—systemic scleroderma	6.14e-05	0.00137	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—IL1B—systemic scleroderma	5.96e-05	0.00133	CbGpPWpGaD
Docetaxel—Dizziness—Prednisone—systemic scleroderma	5.96e-05	0.000216	CcSEcCtD
Docetaxel—Abdominal pain—Methotrexate—systemic scleroderma	5.95e-05	0.000215	CcSEcCtD
Docetaxel—Body temperature increased—Methotrexate—systemic scleroderma	5.95e-05	0.000215	CcSEcCtD
Docetaxel—Vomiting—Prednisone—systemic scleroderma	5.73e-05	0.000207	CcSEcCtD
Docetaxel—Rash—Prednisone—systemic scleroderma	5.68e-05	0.000206	CcSEcCtD
Docetaxel—BCL2—Immune System—CSK—systemic scleroderma	5.68e-05	0.00126	CbGpPWpGaD
Docetaxel—Dermatitis—Prednisone—systemic scleroderma	5.67e-05	0.000205	CcSEcCtD
Docetaxel—Headache—Prednisone—systemic scleroderma	5.64e-05	0.000204	CcSEcCtD
Docetaxel—EGFR—Spinal Cord Injury—MMP9—systemic scleroderma	5.62e-05	0.00125	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IRF5—systemic scleroderma	5.58e-05	0.00124	CbGpPWpGaD
Docetaxel—Hypersensitivity—Methotrexate—systemic scleroderma	5.55e-05	0.000201	CcSEcCtD
Docetaxel—EGFR—Adaptive Immune System—CSK—systemic scleroderma	5.53e-05	0.00123	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—NOS3—systemic scleroderma	5.44e-05	0.00121	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD247—systemic scleroderma	5.42e-05	0.00121	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—ITGAM—systemic scleroderma	5.42e-05	0.00121	CbGpPWpGaD
Docetaxel—Asthenia—Methotrexate—systemic scleroderma	5.4e-05	0.000195	CcSEcCtD
Docetaxel—Nausea—Prednisone—systemic scleroderma	5.35e-05	0.000194	CcSEcCtD
Docetaxel—BCL2—Immune System—ITGAM—systemic scleroderma	5.34e-05	0.00119	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IRF8—systemic scleroderma	5.34e-05	0.00119	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD247—systemic scleroderma	5.34e-05	0.00119	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	5.33e-05	0.00119	CbGpPWpGaD
Docetaxel—Pruritus—Methotrexate—systemic scleroderma	5.33e-05	0.000193	CcSEcCtD
Docetaxel—TUBB2B—Metabolism of proteins—MMP1—systemic scleroderma	5.25e-05	0.00117	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—MMP1—systemic scleroderma	5.25e-05	0.00117	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD247—systemic scleroderma	5.2e-05	0.00116	CbGpPWpGaD
Docetaxel—Diarrhoea—Methotrexate—systemic scleroderma	5.15e-05	0.000186	CcSEcCtD
Docetaxel—EGFR—Innate Immune System—TNFAIP3—systemic scleroderma	5.07e-05	0.00113	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—MMP1—systemic scleroderma	5.07e-05	0.00113	CbGpPWpGaD
Docetaxel—BCL2—Immune System—TNFAIP3—systemic scleroderma	5e-05	0.00111	CbGpPWpGaD
Docetaxel—Dizziness—Methotrexate—systemic scleroderma	4.98e-05	0.00018	CcSEcCtD
Docetaxel—BCL2—Immune System—BLK—systemic scleroderma	4.94e-05	0.0011	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—MMP1—systemic scleroderma	4.91e-05	0.00109	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—MMP9—systemic scleroderma	4.87e-05	0.00109	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.85e-05	0.00108	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—BLK—systemic scleroderma	4.81e-05	0.00107	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—MMP1—systemic scleroderma	4.8e-05	0.00107	CbGpPWpGaD
Docetaxel—Vomiting—Methotrexate—systemic scleroderma	4.79e-05	0.000173	CcSEcCtD
Docetaxel—Rash—Methotrexate—systemic scleroderma	4.75e-05	0.000172	CcSEcCtD
Docetaxel—Dermatitis—Methotrexate—systemic scleroderma	4.74e-05	0.000172	CcSEcCtD
Docetaxel—Headache—Methotrexate—systemic scleroderma	4.72e-05	0.000171	CcSEcCtD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.69e-05	0.00105	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SMAD7—systemic scleroderma	4.67e-05	0.00104	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TGFB1—systemic scleroderma	4.63e-05	0.00103	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CCL2—systemic scleroderma	4.58e-05	0.00102	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—IL1B—systemic scleroderma	4.49e-05	0.001	CbGpPWpGaD
Docetaxel—Nausea—Methotrexate—systemic scleroderma	4.47e-05	0.000162	CcSEcCtD
Docetaxel—EGFR—Disease—SMAD7—systemic scleroderma	4.4e-05	0.00098	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—MMP1—systemic scleroderma	4.31e-05	0.00096	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFBI—systemic scleroderma	4.27e-05	0.000951	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—CCL2—systemic scleroderma	4.27e-05	0.00095	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—CCL2—systemic scleroderma	4.27e-05	0.00095	CbGpPWpGaD
Docetaxel—ABCC2—NRF2 pathway—TGFB1—systemic scleroderma	4.19e-05	0.000934	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	4.15e-05	0.000924	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—CCL2—systemic scleroderma	4.12e-05	0.000918	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—NOS3—systemic scleroderma	4.08e-05	0.000909	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—MMP2—systemic scleroderma	4.06e-05	0.000904	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—MMP2—systemic scleroderma	4.06e-05	0.000904	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CTLA4—systemic scleroderma	4.04e-05	0.000901	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—RHOB—systemic scleroderma	4.03e-05	0.000898	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—HSPG2—systemic scleroderma	4.03e-05	0.000898	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFBI—systemic scleroderma	4.02e-05	0.000896	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—CCL2—systemic scleroderma	3.99e-05	0.000889	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CTLA4—systemic scleroderma	3.94e-05	0.000878	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—MMP1—systemic scleroderma	3.94e-05	0.000878	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—MMP2—systemic scleroderma	3.92e-05	0.000873	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—CCL2—systemic scleroderma	3.9e-05	0.000869	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—MMP2—systemic scleroderma	3.8e-05	0.000846	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—MMP2—systemic scleroderma	3.71e-05	0.000827	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—CCL2—systemic scleroderma	3.5e-05	0.00078	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TGFB1—systemic scleroderma	3.49e-05	0.000778	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HSPG2—systemic scleroderma	3.4e-05	0.000758	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CSK—systemic scleroderma	3.36e-05	0.000747	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—MMP2—systemic scleroderma	3.33e-05	0.000743	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—MMP2—systemic scleroderma	3.33e-05	0.000742	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-DQB1—systemic scleroderma	3.33e-05	0.000742	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IRF5—systemic scleroderma	3.3e-05	0.000735	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CSK—systemic scleroderma	3.29e-05	0.000732	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—MMP9—systemic scleroderma	3.27e-05	0.000729	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-DQB1—systemic scleroderma	3.25e-05	0.000723	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	3.22e-05	0.000718	CbGpPWpGaD
Docetaxel—EGFR—Disease—HSPG2—systemic scleroderma	3.21e-05	0.000715	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—CCL2—systemic scleroderma	3.2e-05	0.000714	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL1A—systemic scleroderma	3.16e-05	0.000705	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IRF8—systemic scleroderma	3.16e-05	0.000703	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD247—systemic scleroderma	3.16e-05	0.000703	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ITGAM—systemic scleroderma	3.16e-05	0.000703	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	3.15e-05	0.000702	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD40LG—systemic scleroderma	3.15e-05	0.000701	CbGpPWpGaD
Docetaxel—EGFR—Disease—CSK—systemic scleroderma	3.1e-05	0.00069	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD247—systemic scleroderma	3.09e-05	0.000688	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SMAD7—systemic scleroderma	3.08e-05	0.000686	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD40LG—systemic scleroderma	3.07e-05	0.000683	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CTGF—systemic scleroderma	3.06e-05	0.000681	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—MMP2—systemic scleroderma	3.05e-05	0.000679	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TNFAIP3—systemic scleroderma	2.95e-05	0.000658	CbGpPWpGaD
Docetaxel—EGFR—Immune System—BLK—systemic scleroderma	2.92e-05	0.00065	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD247—systemic scleroderma	2.91e-05	0.000649	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—HSPG2—systemic scleroderma	2.85e-05	0.000635	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—HSPG2—systemic scleroderma	2.76e-05	0.000614	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TGFB1—systemic scleroderma	2.7e-05	0.000601	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—HSPG2—systemic scleroderma	2.51e-05	0.000559	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—MMP9—systemic scleroderma	2.51e-05	0.000558	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—HSPG2—systemic scleroderma	2.49e-05	0.000554	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTLA4—systemic scleroderma	2.39e-05	0.000533	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RHOB—systemic scleroderma	2.38e-05	0.000531	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MMP2—systemic scleroderma	2.38e-05	0.00053	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HSPG2—systemic scleroderma	2.25e-05	0.0005	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CSK—systemic scleroderma	2.17e-05	0.000483	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CTGF—systemic scleroderma	2.16e-05	0.000481	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CTGF—systemic scleroderma	2.09e-05	0.000465	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—EDN1—systemic scleroderma	2.06e-05	0.000459	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DQB1—systemic scleroderma	1.97e-05	0.000439	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CTGF—systemic scleroderma	1.9e-05	0.000423	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CTGF—systemic scleroderma	1.88e-05	0.00042	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1A—systemic scleroderma	1.87e-05	0.000417	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD40LG—systemic scleroderma	1.86e-05	0.000414	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HSPG2—systemic scleroderma	1.8e-05	0.0004	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MMP9—systemic scleroderma	1.79e-05	0.000398	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL1B—systemic scleroderma	1.65e-05	0.000367	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.59e-05	0.000354	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TGFB1—systemic scleroderma	1.47e-05	0.000328	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL2—systemic scleroderma	1.41e-05	0.000314	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CTGF—systemic scleroderma	1.36e-05	0.000303	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HSPG2—systemic scleroderma	1.36e-05	0.000302	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—NOS3—systemic scleroderma	1.33e-05	0.000296	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EDN1—systemic scleroderma	1.22e-05	0.000271	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOS3—systemic scleroderma	1.12e-05	0.00025	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOS3—systemic scleroderma	1.06e-05	0.000236	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CTGF—systemic scleroderma	1.03e-05	0.000229	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1B—systemic scleroderma	9.75e-06	0.000217	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—NOS3—systemic scleroderma	9.4e-06	0.000209	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—NOS3—systemic scleroderma	9.1e-06	0.000203	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HSPG2—systemic scleroderma	8.36e-06	0.000186	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL2—systemic scleroderma	8.32e-06	0.000185	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—NOS3—systemic scleroderma	8.27e-06	0.000184	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—NOS3—systemic scleroderma	8.2e-06	0.000183	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFB1—systemic scleroderma	7.42e-06	0.000165	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOS3—systemic scleroderma	7.41e-06	0.000165	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFB1—systemic scleroderma	7e-06	0.000156	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CTGF—systemic scleroderma	6.33e-06	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—systemic scleroderma	5.95e-06	0.000132	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—NOS3—systemic scleroderma	5.93e-06	0.000132	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFB1—systemic scleroderma	4.9e-06	0.000109	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NOS3—systemic scleroderma	4.47e-06	9.96e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NOS3—systemic scleroderma	2.76e-06	6.14e-05	CbGpPWpGaD
